Literature DB >> 22417736

Causes of hyperferritinaemia classified by HIV status in a tertiary-care setting in South Africa.

A Visser1, C Mostert.   

Abstract

This study included all patients, with known HIV-1 status, admitted to hospital over a 5-year period with serum ferritin values exceeding 1500 μg/l. Markedly elevated serum ferritin levels are associated with a host of causes which poses a diagnostic dilemma, as the aetiology is often highly dependent on local epidemiology. We evaluated patients' records retrospectively to determine underlying causes of possible hyperferritinaemia. Aetiologies associated with hyperferritinaemia varied significantly depending on HIV-1 status. In patients infected with the HIV-1 virus, infectious causes predominated with Mycobacterium tuberculosis accounting for more than 50% of the patient population with an odds ratio of 17·98 (95% confidence interval 8·31-38·88) in HIV-positive compared to HIV-negative patients. Of the HIV-1-negative patients, hereditary haemochromatosis accounted for less than 2% of patients and chronic renal failure was the most common diagnosis. The finding of hyperferritinaemia should prompt determination of HIV-1 status, as this impacts significantly on aetiological epidemiology. In HIV-1-positive patients, aggressive investigation for mycobacterial infection should be undertaken in cases of combined hyperferritinaemia and positive HIV-1 serology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22417736      PMCID: PMC9152059          DOI: 10.1017/S0950268812000398

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  16 in total

Review 1.  Diagnosis from the blood smear.

Authors:  Barbara J Bain
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

2.  Extreme hyperferritenemia in an AIDS patient with disseminated histoplasmosis.

Authors:  Praveen Guturu; Juan C Sarria
Journal:  J Infect       Date:  2008-08-28       Impact factor: 6.072

3.  Serum ferritin levels correlate with disease activity in patients with AIDS and disseminated histoplasmosis.

Authors:  D H Kirn; D Fredericks; J A McCutchan; D Stites; M Shuman
Journal:  Clin Infect Dis       Date:  1995-10       Impact factor: 9.079

4.  Severe hyperferritinemia in Mycobacteria tuberculosis infection.

Authors:  Adele Visser; A van de Vyver
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

5.  Extreme hyperferritinemia in patients infected with human immunodeficiency virus is not a highly specific marker for disseminated histoplasmosis.

Authors:  S W McKenzie; R T Means
Journal:  Clin Infect Dis       Date:  1997-03       Impact factor: 9.079

Review 6.  Plasma ferritin determination as a diagnostic tool.

Authors:  C A Finch; V Bellotti; S Stray; D A Lipschitz; J D Cook; M J Pippard; H A Huebers
Journal:  West J Med       Date:  1986-11

7.  Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS.

Authors:  C Moroz; S L Misrock; F P Siegal
Journal:  AIDS       Date:  1989-01       Impact factor: 4.177

8.  The effects of blood transfusion on serum ferritin, folic acid, and cobalamin levels.

Authors:  C H Ho
Journal:  Transfusion       Date:  1992-10       Impact factor: 3.157

9.  Serum ferritin and bone marrow iron stores. I. Correlation with absence of iron in biopsy specimens.

Authors:  J R Krause; V Stolc
Journal:  Am J Clin Pathol       Date:  1979-11       Impact factor: 2.493

Review 10.  Secondary hemophagocytic syndrome in adults: a case series of 18 patients in a single institution and a review of literature.

Authors:  Munira Shabbir; John Lucas; John Lazarchick; Keisuke Shirai
Journal:  Hematol Oncol       Date:  2010-08-30       Impact factor: 5.271

View more
  1 in total

1.  HIV-1 infection in sickle cell disease and sickle cell trait: role of iron and innate response.

Authors:  Sergei Nekhai; Namita Kumari
Journal:  Expert Rev Hematol       Date:  2022-03-24       Impact factor: 2.819

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.